Bradley Foster & Sargent’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.4M Sell
220,862
-7,160
-3% -$1.3M 0.46% 50
2026
Q1
$33.5M Sell
228,022
-20,724
-8% -$3.37M 0.52% 51
2025
Q4
$48.5M Sell
248,746
-16,759
-6% -$3.99M 0.71% 39
2025
Q3
$74.7M Buy
265,505
+12,270
+5% +$3.12M 1.1% 24
2025
Q2
$55.4M Sell
253,235
-902
-0.4% -$146K 0.87% 33
2025
Q1
$35.5M Sell
254,137
-5,321
-2% -$866K 0.61% 45
2024
Q4
$43.2M Buy
259,458
+6,973
+3% +$1.24M 0.73% 37
2024
Q3
$43M Buy
252,485
+12,467
+5% +$1.81M 0.72% 40
2024
Q2
$33.9M Buy
240,018
+461
+0.2% +$57.2K 0.61% 47
2024
Q1
$30.1M Sell
239,557
-2,218
-0.9% -$254K 0.54% 54
2023
Q4
$25.5M Buy
241,775
+19,120
+9% +$2.09M 0.5% 52
2023
Q3
$26.5M Hold
222,655
0.56% 52
2023
Q2
$26.5M Sell
222,655
-5,949
-3% -$615K 0.56% 52
2023
Q1
$21.2M Buy
228,604
+472
+0.2% +$41.4K 0.51% 57
2022
Q4
$18.6M Buy
228,132
+16,365
+8% +$1.24M 0.47% 58
2022
Q3
$12.9M Sell
211,767
-5,631
-3% -$412K 0.36% 64
2022
Q2
$15.2M Buy
217,398
+2,459
+1% +$180K 0.39% 61
2022
Q1
$17.8M Sell
214,939
-299,807
-58% -$24.3M 0.38% 64
2021
Q4
$44.9M Sell
514,746
-4,019
-0.8% -$377K 0.93% 33
2021
Q3
$45.2M Buy
518,765
+298,085
+135% +$26.3M 1.06% 24
2021
Q2
$17.2M Sell
220,680
-1,245
-0.6% -$97.5K 0.4% 70
2021
Q1
$15.6M Buy
221,925
+2,238
+1% +$145K 0.39% 68
2020
Q4
$14.2M Sell
219,687
-343
-0.2% -$20.4K 0.38% 69
2020
Q3
$13.1M Buy
+220,030
New +$12.5M 0.38% 67
2020
Q1
$11.6M Buy
239,067
+19,595
+9% +$1.01M 0.46% 63
2019
Q4
$11.6M Buy
219,472
+8,288
+4% +$456K 0.36% 72
2019
Q3
$11.6M Buy
211,184
+3,193
+2% +$176K 0.39% 72
2019
Q2
$11.8M Buy
207,991
+1,484
+0.7% +$80.3K 0.39% 70
2019
Q1
$11.1M Buy
206,507
+9,599
+5% +$489K 0.39% 70
2018
Q4
$8.89M Sell
196,908
-12,705
-6% -$609K 0.36% 71
2018
Q3
$10.8M Buy
209,613
+5,070
+2% +$246K 0.37% 70
2018
Q2
$9.01M Buy
204,543
+114,505
+127% +$5.28M 0.32% 77
2018
Q1
$4.12M Buy
90,038
+43,483
+93% +$2.16M 0.16% 118
2017
Q4
$2.2M Sell
46,555
-718
-2% -$35.2K 0.08% 157
2017
Q3
$2.29M Buy
47,273
+1,456
+3% +$72.4K 0.09% 154
2017
Q2
$2.3M Sell
45,817
-550
-1% -$25.1K 0.09% 149
2017
Q1
$2.07M Sell
46,367
-1,031
-2% -$42.9K 0.08% 153
2016
Q4
$1.82M Sell
47,398
-1,063
-2% -$41.6K 0.08% 163
2016
Q3
$1.9M Sell
48,461
-428
-0.9% -$17.4K 0.08% 150
2016
Q2
$2M Sell
48,889
-98
-0.2% -$3.91K 0.09% 141
2016
Q1
$2M Sell
48,987
-98
-0.2% -$3.63K 0.09% 144
2015
Q4
$1.79M Sell
49,085
-9,896
-17% -$378K 0.08% 159
2015
Q3
$2.13M Sell
58,981
-20,648
-26% -$794K 0.1% 141
2015
Q2
$3.21M Buy
79,629
+326
+0.4% +$14.1K 0.15% 123
2015
Q1
$3.42M Buy
79,303
+737
+0.9% +$31.9K 0.16% 120
2014
Q4
$3.53M Sell
78,566
-1,936
-2% -$78.8K 0.17% 117
2014
Q3
$3.08M Buy
80,502
+20,438
+34% +$828K 0.15% 128
2014
Q2
$2.43M Buy
60,064
+22,832
+61% +$939K 0.12% 135
2014
Q1
$1.52M Buy
37,232
+3,250
+10% +$124K 0.08% 162
2013
Q4
$1.3M Sell
33,982
-2,976
-8% -$102K 0.07% 173
2013
Q3
$1.23M Sell
36,958
-774
-2% -$25.1K 0.07% 164
2013
Q2
$1.16M Buy
+37,732
New +$1.25M 0.07% 159

Other funds holding ORCL

Bradley Foster & Sargent's ORCL Position: Q2 2026 in Review

Bradley Foster & Sargent reduced its Oracle (ORCL) stake by 3.1% in Q2 2026, selling an estimated $1.3M and leaving 220,862 shares worth $32.4M. The position accounts for 0.46% of the portfolio, ranked #50.

Bradley Foster & Sargent first reported a position in ORCL in Q2 2013 and has held it in 52 quarters since. The position peaked at $74.7M in Q3 2025. 3,503 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Bradley Foster & Sargent held 220,862 shares of Oracle worth $32.4M as of Q2 2026.
  • Bradley Foster & Sargent sold 7,160 Oracle shares in Q2 2026, an estimated $1.3M.
  • Oracle made up 0.46% of Bradley Foster & Sargent's portfolio in Q2 2026, its #50 holding.
  • Bradley Foster & Sargent first reported a position in Oracle in Q2 2013 and has held it in 52 quarters since.
  • Bradley Foster & Sargent's Oracle position peaked at $74.7M in Q3 2025.
  • 3,503 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.